Loading...
Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?
Octreotide is a somatostatin analogue used for treating congenital chylothorax and congenital hyperinsulinism in infants. By increasing splanchnic arteriolar resistance and decreasing gastrointestinal blood flow, octreotide indirectly reduces lymphatic flow in chylous effusions. Splanchnic ischaemia...
Na minha lista:
| Udgivet i: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021135/ https://ncbi.nlm.nih.gov/pubmed/32051156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232062 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|